Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
oleh: Jihad Bishara, Silvio Pitlik, Zmira Samra, Itzhak Levy, Mical Paul, Leonard Leibovici
| Format: | Article |
|---|---|
| Diterbitkan: | Centers for Disease Control and Prevention 2003-09-01 |
Deskripsi
Among bloodstream methicillin-resistant Staphylococcus aureus (MRSA) isolates from adult patients in a single hospital, susceptibility to co-trimoxazole increased progressively from 31% in 1988 to 92% in 1997 (p<0.0001). If also observed in other institutions, these findings should encourage the performance of a clinical trial of sufficient size to compare co-trimoxazole to vancomycin in treating MRSA infections.